We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Neural Interface Uses Thoughts to Controls Medical Devices

By HospiMedica International staff writers
Posted on 18 Apr 2019
Print article
Image: The Stentrode system implantable electrode array (Photo courtesy of Synchron).
Image: The Stentrode system implantable electrode array (Photo courtesy of Synchron).
New neural interface technology could restore communication in patients with severe paralysis due to debilitating diseases.

The Synchron (Campbell, CA, USA) Stentrode system is based on a platinum electrode array designed to record electrical frequencies emitted by the brain in people paralyzed due to stroke, motor neuron disease, amyotrophic lateral sclerosis (ALS), and spinal cord injury. The signals are streamed wirelessly to specialized artificial intelligence (AI) and machine learning algorithms that can interpret them and predict brain activity. Mounted on a nitinol endovascular stent, the array is small and flexible enough to be delivered via cerebral angiography, obviating open brain surgery.

Implanted via the jugular vein, the Stentrode is placed inside the brain in the motor cortex. The electrical brain discharge signals are captured and sent to a wireless antenna unit implanted in the chest, which are forwarded to an external receiver. “Thought-to-Text” technology, based on proprietary BrainOS AI modular training software, is then used to teach the patient how to control a digital human application programming interface (API) in order to operate 3rd party assistive devices. The first clinical trial of Stentrode will take place at The Royal Melbourne and Bethlehem Hospitals, both in Melbourne (Australia).

“The initiation of this trial is a milestone for the technology industry and points towards a new form of treatment for people with paralysis. There is currently no means for recovery for patients beyond the natural healing process,” said neurointerventionalist Thomas Oxley, MD, PhD, of Mount Sinai Hospital (New York, NY, USA), and CEO of Synchron. “The coupling of the Stentrode with our BrainOS technology represents a potential solution to enable people to regain control of their world, but with digital means. For people who have lost the ability to communicate, this technology could be life changing.”

Direct electrical stimulation and recording of brain activity requires invasive procedures, such as the removal of a portion of the skull or the drilling of a burr hole. Also, electrode implantation into tissue can cause inflammatory tissue responses and brain trauma, and lead to device failure.

Related Links:
Synchron

Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
LED Phototherapy System
Bililed Mini+

Print article

Channels

Critical Care

view channel
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)

New Device Treats Acute Kidney Injury from Sepsis

Sepsis, commonly referred to as "blood poisoning," can occur due to any infectious agent, triggering a systemic response by the body to combat the infection. This response involves the activation of circulating... Read more

Surgical Techniques

view channel
Image: The endoscopic device can 3D image the stiffness of individual biological cells and complex organisms (Photo courtesy of University of Nottingham)

World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis

In the early stages of cancer, the cells are significantly softer than normal cells, which facilitates their movement through small spaces and contributes to the rapid spread of the disease, a process... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.